Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.
Shaanxi Panlong Pharmaceutical Group Co OCF Yield % Explanation
Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Shaanxi Panlong Pharmaceutical Group Co OCF Yield % Related Terms
Shaanxi Panlong Pharmaceutical Group Co OCF Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Panlong Pharmaceutical Group Co OCF Yield % Chart
Shaanxi Panlong Pharmaceutical Group Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Shaanxi Panlong Pharmaceutical Group Co's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shaanxi Panlong Pharmaceutical Group Co OCF Yield % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) has a OCF Yield % of 5.99 as of Sep. 03, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. This is 77% above median its historical median of 3.38. Over the past decade, Shaanxi Panlong Pharmaceutical Group Co's OCF Yield % has ranged from 0.48 to 6.99. According to the industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #358 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 35.6%.
Is Shaanxi Panlong Pharmaceutical Group Co's OCF Yield % too high?
Shaanxi Panlong Pharmaceutical Group Co's current OCF Yield % of 5.99 is 77% above median its 10-year median of 3.38. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 6.99. The Drug Manufacturers industry median OCF Yield % is 3.39. Shaanxi Panlong Pharmaceutical Group Co's value of 5.99 is 76.7% above this industry median. Based on the distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #358 out of 1005 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shaanxi Panlong Pharmaceutical Group Co has a GF Score™ of 82/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shaanxi Panlong Pharmaceutical Group Co's OCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shaanxi Panlong Pharmaceutical Group Co ranks #358 out of 1005 companies for OCF Yield %. This puts Shaanxi Panlong Pharmaceutical Group Co in the upper half of its industry. The industry median OCF Yield % is 3.39. Shaanxi Panlong Pharmaceutical Group Co's value of 5.99 is 76.7% above this benchmark. Historically, Shaanxi Panlong Pharmaceutical Group Co's own OCF Yield % has ranged from 0.48 to 6.99 over the past decade. While the company's 10-year median is 3.38 vs. the industry median of 3.39, Shaanxi Panlong Pharmaceutical Group Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Drug Manufacturers company?
The median OCF Yield % among Drug Manufacturers companies is 3.39, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shaanxi Panlong Pharmaceutical Group Co's current OCF Yield % of 5.99 is 76.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Shaanxi Panlong Pharmaceutical Group Co and its competitors. For the Drug Manufacturers industry, the median OCF Yield % is 3.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shaanxi Panlong Pharmaceutical Group Co's current OCF Yield % is 5.99, which is 77% above median its own 10-year median of 3.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shaanxi Panlong Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) is currently considered Fairly Valued. The stock's GF Value™ is ¥21.62, compared to a current price of ¥21.62 — trading right at its estimated fair value. The current OCF Yield % is 5.99, which is 77% above median its 10-year median of 3.38 and 76.7% above the Drug Manufacturers industry median of 3.39. Shaanxi Panlong Pharmaceutical Group Co's overall GF Score™ is 82/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864), the current OCF Yield % is 5.99 as of Sep. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shaanxi Panlong Pharmaceutical Group Co (SZSE:002864) Overvalued in 2026?
Based on GuruFocus' analysis, Shaanxi Panlong Pharmaceutical Group Co stock appears to be undervalued.
The current stock price of ¥21.62 is trading 0% below its estimated GF Value™ of ¥21.62.
GuruFocus considers Shaanxi Panlong Pharmaceutical Group Co to be Fairly Valued.
Key valuation signals for SZSE:002864:
OCF Yield %: 5.99 (77% above median its 10-year median of 3.38)
GF Value™: ¥21.62 vs. price of ¥21.62 (0% below fair value)
Industry Position: 76.7% above the Drug Manufacturers median (#358 of 1005)
No single metric tells the full story. See the SZSE:002864 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shaanxi Panlong Pharmaceutical Group Co Ltd is engaged in the cultivation of medicinal herbs under Good Agricultural Practices (GAP), pharmaceutical production, research and development, sales, and logistics activities. Its business scope also includes technology and goods import and export, import and export agency services, medical research and experimental development, and the sale of hygiene products, disposable medical supplies, and disinfectants.
82GF Score
Get the complete analysis for SZSE:002864
OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:002864 has been successfully added to your 
